SHANGHAI, CHINA, February 28, 2023 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherap...
hepatocellular-carcinoma
November 2022: The Food and Drug Administration approved tremelimumab (Imjudo, AstraZeneca Pharmaceuticals) in combination with durvalumab for adult patients with unresectable hepatocellular carcinoma...
hepatocellular-carcinoma
On January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular carcinoma (HCC) who have previously been treat...
hepatocellular-carcinoma
Liver Cancer Treatment
Liver cancer is a dangerous and life-threatening disease in need of timely diagnosis and treatment. Thanks to advances in medical technology, treatment including surgery, chemo...
hepatocellular-carcinoma